Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1876 2
1880 1
1884 1
1888 3
1890 1
1891 1
1892 2
1894 1
1896 2
1897 2
1898 1
1900 1
1901 1
1902 1
1903 2
1906 3
1907 1
1908 2
1909 7
1910 5
1911 4
1913 4
1914 3
1915 1
1918 3
1920 3
1921 2
1922 4
1923 3
1924 20
1925 7
1926 1
1927 1
1928 2
1929 1
1930 2
1931 2
1933 7
1934 3
1935 4
1936 4
1937 5
1938 4
1939 3
1940 7
1941 5
1942 4
1943 6
1944 4
1945 30
1946 84
1947 104
1948 125
1949 156
1950 418
1951 614
1952 529
1953 468
1954 483
1955 442
1956 441
1957 443
1958 510
1959 316
1960 297
1961 486
1962 517
1963 814
1964 1020
1965 857
1966 812
1967 956
1968 1065
1969 1243
1970 1157
1971 1238
1972 1295
1973 1348
1974 1351
1975 1428
1976 1382
1977 1377
1978 1363
1979 1406
1980 1343
1981 1502
1982 1539
1983 1773
1984 1708
1985 1707
1986 1906
1987 1882
1988 2096
1989 2091
1990 2043
1991 2052
1992 2209
1993 2218
1994 2153
1995 2223
1996 2265
1997 2242
1998 2260
1999 2513
2000 2426
2001 2626
2002 2913
2003 3014
2004 3262
2005 3897
2006 3735
2007 4086
2008 4022
2009 4440
2010 4670
2011 5059
2012 5379
2013 5326
2014 5757
2015 5742
2016 5862
2017 5926
2018 6011
2019 6194
2020 6575
2021 493
Text availability
Article attribute
Article type
Publication date

Search Results

152,958 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and management of rheumatoid arthritis.
Wasserman AM. Wasserman AM. Am Fam Physician. 2011 Dec 1;84(11):1245-52. Am Fam Physician. 2011. PMID: 22150658 Free article. Review.
Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis. ...In a patient with inflammatory arthritis, the presence of a rheumatoid factor or anti-citrullinated protein antibody, or elevated C-reactive protein level or
Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis. ...In a patient with inflammatory
Rheumatoid arthritis.
Scott DL, Wolfe F, Huizinga TW. Scott DL, et al. Lancet. 2010 Sep 25;376(9746):1094-108. doi: 10.1016/S0140-6736(10)60826-4. Lancet. 2010. PMID: 20870100 Review.
Rheumatoid arthritis is characterised by persistent synovitis, systemic inflammation, and autoantibodies (particularly to rheumatoid factor and citrullinated peptide). 50% of the risk for development of rheumatoid arthritis is attributable to ge
Rheumatoid arthritis is characterised by persistent synovitis, systemic inflammation, and autoantibodies (particularly to r
Rheumatoid arthritis.
Smolen JS, Aletaha D, McInnes IB. Smolen JS, et al. Lancet. 2016 Oct 22;388(10055):2023-2038. doi: 10.1016/S0140-6736(16)30173-8. Epub 2016 May 3. Lancet. 2016. PMID: 27156434 Review.
Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability. ...In this Seminar, we describe current insights into genetics and aetiology, pathophysiology, epidemiology, assessment, therapeutic agents
Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability.
Rheumatoid arthritis.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2018 Feb 8;4:18002. doi: 10.1038/nrdp.2018.2. Nat Rev Dis Primers. 2018. PMID: 29417950 Review. No abstract available.
The pathogenesis of rheumatoid arthritis.
McInnes IB, Schett G. McInnes IB, et al. N Engl J Med. 2011 Dec 8;365(23):2205-19. doi: 10.1056/NEJMra1004965. N Engl J Med. 2011. PMID: 22150039 Review. No abstract available.
Rheumatoid arthritis.
Ngian GS. Ngian GS. Aust Fam Physician. 2010 Sep;39(9):626-8. Aust Fam Physician. 2010. PMID: 20877764 Free article. Review.
BACKGROUND: Rheumatoid arthritis is a chronic disease that can cause irreversible joint damage and significant disability. ...Methotrexate is usually the first line agent in the management of rheumatoid arthritis but simple analgesia and nonsteroidal a …
BACKGROUND: Rheumatoid arthritis is a chronic disease that can cause irreversible joint damage and significant disability. ... …
Rheumatoid arthritis.
Lee DM, Weinblatt ME. Lee DM, et al. Lancet. 2001 Sep 15;358(9285):903-11. doi: 10.1016/S0140-6736(01)06075-5. Lancet. 2001. PMID: 11567728 Review.
Rheumatoid arthritis is a systemic inflammatory disorder that mainly affects the diarthrodial joint. ...The continuing elucidation of pathophysiological pathways relevant in rheumatoid arthritis, coupled with continuing advances in biotechnology and ra
Rheumatoid arthritis is a systemic inflammatory disorder that mainly affects the diarthrodial joint. ...The continuing elucida
[Rheumatoid arthritis].
Devauchelle-Pensec V, Guellec D. Devauchelle-Pensec V, et al. Rev Prat. 2015 May;65(5):719-29. Rev Prat. 2015. PMID: 26165118 Review. French. No abstract available.
Advances in the Treatment of Rheumatoid Arthritis: Costs and Challenges.
Pisetsky DS. Pisetsky DS. N C Med J. 2017 Sep-Oct;78(5):337-340. doi: 10.18043/ncm.78.5.337. N C Med J. 2017. PMID: 28963273 Free article.
Rheumatoid arthritis is the most common form of inflammatory arthritis. ...
Rheumatoid arthritis is the most common form of inflammatory arthritis. ...
Rheumatoid arthritis pharmacogenomics.
Marsal S, Julià A. Marsal S, et al. Pharmacogenomics. 2010 May;11(5):617-9. doi: 10.2217/pgs.10.53. Pharmacogenomics. 2010. PMID: 20415547 Free article. Review.
Rheumatoid arthritis is a highly heterogeneous disease in all its aspects, including response to therapy. ...One of the main aims for pharmacogenomics of rheumatoid arthritis for the next few years will be to accurately identify, from available therapi
Rheumatoid arthritis is a highly heterogeneous disease in all its aspects, including response to therapy. ...One of the main a
152,958 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback